Toggle Main Menu Toggle Search

Open Access padlockePrints

First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AGO14699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM)

Lookup NU author(s): Professor Ruth Plummer, Professor Alan Calvert


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Plummer ER, Lorigan P, Evans J, Steven N, Middleton M, Wilson R, Snow K, Dewji R, Calvert AH

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Oncology

Year: 2006

Volume: 24

Issue: 18 (Part 1 Suppl. S)

Pages: 456S-456S

ISSN (print): 0732-183X

ISSN (electronic): 1527-7755

Notes: From conference: 42nd Annual Meeting of the American Society of Clinical Oncology, 02-06 June 2006, Atlanta, GA.